Literature DB >> 12376561

Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin.

Catherine McCaig1, Claire M Perks, Jeff M P Holly.   

Abstract

The insulin-like growth factor binding proteins (IGFBPs) have IGF-independent differential effects on cell function. We investigated whether they can affect integrin-receptor-mediated cell attachment to different extracellular matrix (ECM) components in Hs578T cells. Cell attachment to a general ECM gel was unaffected by IGFBP-1 and -6 but was significantly increased by IGFBP-4 and -5 and decreased by IGFBP-2 and -3. Similar results were obtained for attachment to laminin or collagen type IV. Attachment to fibronectin, however, was increased by IGFBP-3 and decreased by IGFBP-5. The actions of IGFBP-3 and -5 on cell attachment to ECM were lost in the presence of a soluble Arg-Gly-Asp (RGD)-containing fibronectin fragment. Thrombospondin reversed the actions of IGFBP-3 on cell attachment, but IGFBP-5 still increased cell attachment. On plastic, neither IGFBP-3 nor -5 alone affected cell viability; although ceramide-induced apoptosis was enhanced by IGFBP-3 but reduced by IGFBP-5. The presence of RGD reversed the action of IGFBP-5 on cell death but attenuated that of IGFBP-3. With cells grown on fibronectin, the action of IGFBP-3 was reversed, and it conferred cell survival, whereas the survival effect of IGFBP-5 was lost. In summary we have demonstrated that IGFBP-3 and -5 both have intrinsic effects on cell survival. In each case the presence of fibronectin or fibronectin fragments determines whether susceptibility to apoptosis is increased or decreased. These effects on cell survival are paralleled by acute effects on integrin receptor function; IGFBP-3 and -5 were able to either enhance or inhibit cell attachment in the presence of fibronectin. Cell survival is tightly controlled by cues from the ECM and from growth factors, particularly the IGFs. Our findings indicate that, in addition to being crucial modulators of IGF actions, the IGFBPs have direct actions on cell attachment and survival that are specific and dependent upon the matrix components present.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376561     DOI: 10.1242/jcs.00097

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  36 in total

1.  A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles.

Authors:  Dingfeng Jiang; Naiqing Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-08       Impact factor: 4.553

Review 2.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

Review 3.  Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.

Authors:  Nalo Hamilton; Diana Marquez-Garban; Vei H Mah; Yahya Elshimali; David Elashoff; Edward B Garon; Jaydutt Vadgama; Richard Pietras
Journal:  Crit Rev Oncog       Date:  2015

4.  Fibulin-3 promotes muscle-invasive bladder cancer.

Authors:  A L Han; B A Veeneman; L El-Sawy; K C Day; M L Day; S A Tomlins; E T Keller
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

5.  Breast Cancer Incidence and Mortality by Molecular Subtype: Statewide Age and Racial/Ethnic Disparities in New Jersey.

Authors:  Aishwarya Kulkarni; Antoinette M Stroup; Lisa E Paddock; Stephanie M Hill; Jesse J Plascak; Adana A M Llanos
Journal:  Cancer Health Disparities       Date:  2019-08-19

6.  Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

Authors:  Woo-Young Kim; Mi-Jung Kim; Hojin Moon; Ping Yuan; Jin-Soo Kim; Jong-Kyu Woo; Guangcheng Zhang; Young-Ah Suh; Lei Feng; Carmen Behrens; Carolyn S Van Pelt; Hyunseok Kang; J Jack Lee; Waun-Ki Hong; Ignacio I Wistuba; Ho-Young Lee
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

7.  Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer.

Authors:  Claire M Perks; Jeff Mp Holly
Journal:  J Cell Commun Signal       Date:  2015-04-29       Impact factor: 5.782

8.  Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells.

Authors:  Aleksandar Sokolović; Milka Sokolović; Willem Boers; Ronald Pj Oude Elferink; Piter J Bosma
Journal:  Fibrogenesis Tissue Repair       Date:  2010-02-17

9.  Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.

Authors:  Wensen Chen; Sumin Wang; Tian Tian; Jianling Bai; Zhibin Hu; Yan Xu; Jing Dong; Feng Chen; Xinru Wang; Hongbing Shen
Journal:  Eur J Hum Genet       Date:  2009-06-03       Impact factor: 4.246

10.  Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity.

Authors:  Janet L Martin; Mike Z Lin; Eileen M McGowan; Robert C Baxter
Journal:  J Biol Chem       Date:  2009-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.